U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Links from BioSample

SRX21233066: GSM7678273: LNT1; Bifidobacterium catenulatum subsp. kashiwanohense; RNA-Seq
1 ILLUMINA (NextSeq 500) run: 43.9M spots, 3.3G bases, 1.4Gb downloads

External Id: GSM7678273_r1
Submitted by: Sanford Burnham Prebys Medical Discovery Institute
Study: Integrative genomic reconstruction of carbohydrate utilization networks in bifidobacteria: global trends, local variability, and dietary adaptation
show Abstracthide Abstract
Bifidobacteria are among the earliest colonizers of the human gut, conferring multiple health benefits. While multiple Bifidobacterium strains are used as probiotics, accumulating evidence suggests that the individual responses to probiotic supplementation may vary, likely due to a variety of factors, including strain type(s), gut community composition, dietary habits of the consumer, and other health/lifestyle conditions. Given the saccharolytic nature of bifidobacteria, the carbohydrate composition of the diet is one of the primary factors dictating the colonization efficiency of Bifidobacterium strains. Therefore, a comprehensive understanding of bifidobacterial glycan metabolism at the strain level is necessary to rationally design probiotic or synbiotic formulations that combine bacterial strains with glycans that match their nutrient preferences. In this study, we systematically reconstructed 66 pathways involved in the utilization of mono-, di-, oligo-, and polysaccharides by analyzing the representation of 565 curated functional roles (catabolic enzymes, transporters, transcriptional regulators) in 2973 non-redundant cultured Bifidobacterium isolates and metagenome-assembled genomes (MAGs). Our analysis uncovered substantial heterogeneity in the predicted glycan utilization capabilities at the species and strain level and revealed the presence of a yet undescribed phenotypically distinct clade within the Bifidobacterium longum species. We also identified Bangladeshi isolates harboring unique gene clusters tentatively implicated in the breakdown of xyloglucan and human milk oligosaccharides. Predicted carbohydrate utilization phenotypes were experimentally characterized and validated. Our large-scale genomic analysis expands the knowledge of carbohydrate metabolism in bifidobacteria and provides a foundation for rationally designing single- or multi-strain probiotic formulations of a given bifidobacterial species as well as synbiotic combinations of bifidobacterial strains matched with their preferred carbohydrate substrates. Overall design: Three biological replicates were analyzed for each of the four conditions (growth in the medium supplemented with different carbon sources)
Library:
Name: GSM7678273
Instrument: NextSeq 500
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: SINGLE
Construction protocol: Frozen cell pellets obtained from 2 ml of early exponential phase cultures (OD600=0.35) were resuspended in a solution containing 710 µL of the extraction mixture (200 mM NaCl, 20 mM EDTA, 20% SDS), 500 µL of phenol:chloroform:isoamyl alcohol (125:24:1, pH 4.5), and 250 µL of acid-washed glass beads (212-300 µm). Cells were disrupted using Bead Ruptor 12 (Omni International) by alternating 2 min of homogenizing at 6 m/s and 2 min of cooling on ice. Cellular debris was removed by centrifugation (16,000 × g for 10 min), and the aqueous phase was collected. RNA was precipitated with isopropanol and sodium acetate (pH 5.5) at −20 °C overnight, washed twice in ice-cold 70% ethanol, and resuspended in 100 µL of nuclease-free water. Total RNA was subjected to two consecutive DNase treatments (30 min each) with Turbo DNase (Ambion) and Baseline-ZERO DNase (Lucigen), respectively. Each treatment was followed by cleanup using MEGAclear Transcription Clean-Up Kit (Ambion). RNA was quantified via Qubit Broad Range RNA Assay Kit (Invitrogen), and RNA integrity was confirmed by gel electrophoresis in 1 % agarose and 4200 TapeStation System (Agilent). All samples had RIN > 8.0 Ribosomal RNA was depleted with the NEBNext rRNA depletion kit for bacteria (New England Biolabs) and a set of 20 pooled sequence-specific probes for B. kashiwanohense Bg42221_1E1 designed with NEBNext Custom RNA Depletion Design Tool v1.0. Barcoded libraries were made with NEBNext Ultra II directional RNA library prep kit for Illumina (New England Biolabs). Libraries were pooled and sequenced (single-end 75-bp reads) on Illumina NextSeq 500 using the High Output V2 kit (Illumina).
Runs: 1 run, 43.9M spots, 3.3G bases, 1.4Gb
Run# of Spots# of BasesSizePublished
SRR2550220043,897,9903.3G1.4Gb2024-08-08

ID:
28669691

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...